Mahindra Reports 26% Growth in July Sales, Tractor Sales Jump 20%
Mahindra reported a 26% year-on-year increase in total vehicle sales in July 2026, driven by strong SUV demand, higher tractor sales, and continued growth in its commercial vehicle business.
Mahindra Reports Strong July Sales Across Auto, Farm & CV Businesses
Mahindra & Mahindra reported total vehicle sales of 1,03,860 units (including exports) in July 2026, up 26% from the same month last year. The company's automotive business continued to witness healthy demand, while its farm equipment division benefited from favourable monsoon conditions and improved rural sentiment.
In the commercial vehicle segment, Mahindra posted solid growth across cargo and passenger vehicles. Exports also recorded a strong increase, reflecting steady demand in international markets.
Mahindra Records Broad-Based July Sales Growth Across Key Business Segments
Automotive Business
- Total vehicle sales (including exports): 1,03,860 units, up 26% YoY.
- Domestic SUV sales: 60,048 units, up 20% YoY.
- Domestic commercial vehicle sales: 25,204 units, up 23% YoY.
- Exports: 4,070 units, registering 47% YoY growth.
Farm Equipment Business
- Total tractor sales (Domestic + Exports): 34,420 units, up 20% YoY.
- Domestic tractor sales: 32,643 units, up 21% YoY.
The company attributed the strong performance to good rainfall, improved reservoir levels, faster kharif sowing, supportive government measures, and healthy farm cash flows, which boosted rural demand.
Trucks & Buses Business
- The Trucks and Buses (CV > 3.5T) segment sold 3,009 vehicles, up 19% YoY.
- Cargo vehicle sales increased 15% to 1,474 units.
- Passenger vehicle sales rose 23% to 1,535 units, reflecting healthy demand across the segment.
What to Watch Next
Going forward, investors will monitor whether strong rural demand, favourable monsoon conditions, and continued momentum in the SUV segment help Mahindra sustain its sales growth in the coming months. Performance in exports and the commercial vehicle business will also remain key indicators.
Disclaimer
Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI, and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. Choice Equity Broking Private Limited: SEBI Reg No. Broking - INZ000160131 ( BSE - 3299 ) | ( NSE - 13773 ) | ( MSEI - 73200 ) | ( MCX - 40585 ) | ( NCDEX - 01006 ). Depository Participant SEBI Reg. No. - IN - DP - 84 - 2015, DP ID CDSL - 12066900, NSDL ID - IN301895. Research Analyst - INH000000222 (CIN. NO.: U65999MH2010PTC198714)
Other News
Dr. Reddy's Receives US FDA Approval for Rituximab Biosimilar
Dr. Reddy's Laboratories has received approval from the U.S. Food and Drug Administration (FDA) for its rituximab biosimilar, marking another milestone in the company's global biosimilars business. The product will be commercialized in the United States through its partnership with Fresenius Kabi.
Aether Industries Reports 33% Growth in Q1 FY26 Profit; Board Approves Director Re-appointments
Aether Industries Ltd. announced its consolidated financial results for the first quarter of FY26, reporting growth in revenue and profitability. The Board also approved the re-appointment of key directors, appointed internal and cost auditors for FY27, designated senior managerial personnel, and announced the schedule for its 14th Annual General Meeting (AGM).
PVV Infra Bags Two NHAI Wayside Amenities Projects in Madhya Pradesh
PVV Infra Ltd has received two Letters of Award (LOAs) from National Highways Logistics Management Limited (NHLML), a wholly owned special purpose vehicle (SPV) of the National Highways Authority of India (NHAI), for the development, operation, and maintenance of wayside amenities in Madhya Pradesh. The projects are expected to strengthen the company's presence in the highway infrastructure segment.